3 ml of semaglutide Flex-Dose Injectable 2.5 mg/mL Ozempic (Semaglutide) 2mg Dose Pen

In the 2021 trial of 1,973 patients, tirzepatide led to a 2-5% greater incidence of these gastrointestinal adverse events.3 Semaglutide Most accessible peptide for weight loss, with a lower side effect risk Pros Most widely available GLP-1 treatment for weight loss Has led to dramatic weight loss in clinical studies Less risk of side effects compared to tirzepatide Usually only a once-a-week administration Cons Not as effective for weight loss as tirzepatide according to the scientific literature Semaglutide may not have the double-duty action of tirzepatide, but its still a highly effective treatment for achieving rapid weight loss

during the treatment process

Semaglutide is a GLP-1 receptor agonist with a 94% structural homology to human GLP-1

Method for preparing in vivo formulation: Take Note: 1